AGAdrian Galiana-Bordera

Adrian Galiana-Bordera

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adrian Galiana-Bordera has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bridging the AI chasm in oncology: a standardized platform to enable the in silico clinical validation of AI models within the CHAIMELEON Project

    by Adrian Galiana-Bordera, Javier Aquerreta-Escribano, Pedro Miguel Martinez-Girones, Pau Lozano, Gloria Ribas, Paula Jimenez-Gomez, J. Damián Segrelles Quilis, Leonor Cerda-Alberich, Ignacio Blanquer-Espert, Luis Marti-Bonmati

    Objective: Artificial intelligence (AI) shows promise for improving cancer management, but clinical adoption is limited by the absence of standardized validation tools. As an important step toward bridging the AI chasm, the European CHAIMELEON project addresses this gap by developing a platform for in silico validation of AI models in oncology, aligned with the EUCAIM project. Materials and methods: We designed a web-based platform using Kubernetes microservices architecture, integrating imaging, clinical, and AI components. The backend combines a REST API, an ORTHANC-PACS, and a Keycloak/OAuth2 security layer. The frontend includes a customized OHIF DICOM viewer for oncological case review. Clinicians evaluated cases across three sequential stages: (1) Standard clinical assessment, (2) Assessment with AI predictions, and (3) Final review against clinical endpoint ground truth. The platform also collects clinicians’ perceptions of AI utility, trust, workflow integration, and usability through a Likert-scale questionnaire. Results: The platform provided efficient access to multimodal data for five cancer types. Clinicians completed structured validations, and survey responses indicated favorable perceptions: 93% found the platform intuitive, over 80% would recommend it, and agreement on AI utility exceeded 40% across most endpoints, indicating a positive reception of the AI as a supportive “second reader” tool that prompts clinical re-evaluation rather than simple consensus. Workflow impact was rated positively, underlining the potential to support clinical decision-making. Conclusion: This platform offers a reproducible, scalable, and user-friendly environment for clinical validation of AI models in oncology. Its modular architecture allows integration of additional AI models and is designed to ensure sustainability and interoperability, fostering evidence-based AI adoption in European radiology practice. Trial registration: ClinicalTrials.gov, NCT06950996. Key Points: How can the medical community standardize the in silico clinical validation of oncology AI models to safely bridge the gap before real-world deployment? We successfully implemented a web-based microservices platform, demonstrating high clinical usability and defining human-AI trust dynamics across five distinct cancer types. This standardized validation framework directly enhances diagnostic confidence and interdisciplinary medical collaboration, bridging technical performance with clinical trust to ensure that innovative artificial intelligence technologies safely optimize daily treatment decisions and ultimately maximize therapeutic success and safety for oncology patients.

  • Open Access

    In-silico patient-specific modelling of prostate cancer: Predicting PSA dynamics and treatment response

    by Ángela Pérez-Benito, Adrián Galiana-Bordera, Pedro-Miguel Martínez-Gironés, Gemma Urbanos, Anna Nogué Infante, María José Gómez-Benito, María Ángeles Pérez

  • Transforming experimental radiology: Design and implementation of an innovative ePACS image storage system for AI imaging research environments

    by Ignacio Gómez-Rico Junquero, Pedro-Miguel Martinez-Girones, Adrian Galiana-Bordera, Antonio Orduña Galán, Sonia Ginés, Cayetano Miguel Hernández Marín, Luis Martí-Bonmatí


  • Open Access

    Hardware Architectures for Real-Time Medical Imaging

    by Eduardo Alcaín, Pedro R. Fernández, Rubén Nieto, Antonio S. Montemayor, Jaime Vilas, Adrian Galiana-Bordera, Pedro Miguel Martinez-Girones, Carmen Prieto-De-La-Lastra, Borja Rodriguez-Vila, Marina Bonet, et al.

    Medical imaging is considered one of the most important advances in the history of medicine and has become an essential part of the diagnosis and treatment of patients. Earlier prediction and treatment have been driving the acquisition of higher image resolutions as well as the fusion of different modalities, raising the need for sophisticated hardware and software systems for medical image registration, storage, analysis, and processing. In this scenario and given the new clinical pipelines and the huge clinical burden of hospitals, these systems are often required to provide both highly accurate and real-time processing of large amounts of imaging data. Additionally, lowering the prices of each part of imaging equipment, as well as its development and implementation, and increasing their lifespan is crucial to minimize the cost and lead to more accessible healthcare. This paper focuses on the evolution and the application of different hardware architectures (namely, CPU, GPU, DSP, FPGA, and ASIC) in medical imaging through various specific examples and discussing different options depending on the specific application. The main purpose is to provide a general introduction to hardware acceleration techniques for medical imaging researchers and developers who need to accelerate their implementations.